Naoko Yokohori Akitoshi Sato Mizue Hasegawa Hideki Katsura Kenzo Hiroshima Tamiko Takemura
10.2169/internalmedicine.56.6995
Intern Med
2017;56(1):73-78.
CC BY-NC-ND
https://pubmed.ncbi.nlm.nih.gov/28050003/
Bronchial Diseases / diagnosis Drug Combinations Erythromycin / therapeutic use Lung Diseases, Interstitial / diagnosis Lung Diseases, Interstitial / drug therapy Pyridones / therapeutic use
Bronchial Diseases / diagnosis Drug Combinations Erythromycin / therapeutic use Lung Diseases, Interstitial / diagnosis Lung Diseases, Interstitial / drug therapy Pyridones / therapeutic use Case Reports Aged Bronchiolitis / pathology Haemophilus Infections / pathology Human T-lymphotropic virus 1 / pathogenicity Humans Leukemia-Lymphoma, Adult T-Cell / pathology Lung Diseases, Interstitial / virology Male Drug Combinations Pyridones Erythromycin pirfenidone Diffuse panbronchiolitis
PMC5313428
28050003
Effectiveness of Combined Therapy with Pirfenidone and Erythromycin for Unclassifiable Interstitial Pneumonia Induced by HTLV-1-associated Bronchioloalveolar Disorder (HABA)
2017